AN VAGENENDE
The computed 12-month bankruptcy probability of AN VAGENENDE is 2.1% (moderate). The 2024 annual accounts show equity of €82k and a net result of €38k. Equity is growing by ~58.2% per year across the filed fiscal years. Its solvency ranks better than 72% of 6722 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €82k |
| Net result | €38k |
| Better than sector | 72% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 44.6% | 20.4% | |
| Net result | €38k | €4k | |
| Equity | €82k | €16k | |
| Gross operating margin | €100k | €24k | |
| Staff costs | €17k | €33k |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €74k |
| Net profit | €38k |
| Cash flow | €40k |
| Staff costs | €17k |
| Income taxes | €20k |
| Dividends | - |
| Total assets | €185k |
| Equity | €82k |
| Debt | €102k |
| of which ≤ 1y | €22k |
| of which > 1y | €71k |
| Working capital | €44k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.00 |
| Quick ratio | 3.00 |
| Working capital ratio | 24.0% |
| Solvency | 44.6% |
| Debt / equity | 1.24 |
| Long-term debt ratio | 0.87 |
| Interest coverage | 3.84 |
| Gross margin | - |
| Net margin | - |
| ROA | 20.5% |
| ROE | 45.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (26 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €185k |
| Fixed assets | 21/28 | €118k |
| Intangible fixed assets | 21 | €0 |
| Tangible fixed assets | 22/27 | €21k |
| Financial fixed assets | 28 | €97k |
| Current assets | 29/58 | €66k |
| Stocks & contracts in progress | 3 | €0 |
| Amounts receivable within one year | 40/41 | €9k |
| Cash & bank | 54/58 | €57k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €185k |
| Equity | 10/15 | €82k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €78k |
| Accumulated profits (losses) | 14 | €-388 |
| Amounts payable | 17/49 | €102k |
| Amounts payable after one year | 17 | €71k |
| Amounts payable within one year | 42/48 | €22k |
| Trade debts payable within one year | 44 | €0 |
| Income statement | ||
| Gross operating margin | 9900 | €100k |
| Operating result | 9901 | €71k |
| Financial income | 75 | €6k |
| Financial charges | 65 | €19k |
| Result before taxes | 9903 | €58k |
| Income taxes | 67/77 | €20k |
| Net result for the period | 9904 | €38k |
| Result to be appropriated | 9905 | €38k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 24-06-2021 |
| Status | Active |
| Postal code | 9100 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46443E2482/00A000 | Flanders | 250 m² | 1 · 232 m² | 18.2 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
28-12-2023 Articles of association amended, translation of the articles, coordination of the articles and full restatement of the articles
Technical details
{
"notary": {
"name": "FRANK DESMET",
"firm_city": null,
"firm_name": null,
"office_city": "Eeklo",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-28",
"filing_date": "2023-12-22",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DOEL"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-20",
"unanimous": true
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"targeted_amendment",
"legal_form_change",
"wvv_adaptation",
"name_change",
"object_change",
"duration_change"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0770.279.077",
"name_full_after": "An Vagenende",
"legal_form_after": "BESloten Vennootschap",
"name_full_before": "MARKTAPOTHEEK VAGENENDE",
"current_zetel_raw": "Parkstraat 1, 9100 Sint-Niklaas",
"legal_form_before": "BESloten Vennootschap"
},
"special_mandates": [
{
"holder_kbo": "0810.521.904",
"holder_name": "IDAB",
"scope_categories": [
"kbo",
"ubo",
"btw",
"estox",
"publication"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "De vennootschap neemt de vorm aan van een besloten vennootschap en verkrijgt de naam \u0022An Vagenende\u0022.",
"new_text": "Artikel 1: Naam en rechtsvorm\nDe vennootschap neemt de vorm aan van een besloten vennootschap.\nZij verkrijgt de naam \u0022An Vagenende\u0022.",
"change_kind": "amended",
"article_title": "Naam en rechtsvorm",
"article_number": "1"
},
{
"summary": "De vennootschap heeft tot voorwerp een uitgebreide lijst van activiteiten in Belgi\u00EB en het buitenland, waaronder het oprichten en uitbaten van apotheken, handel in farmaceutische producten, diverse diensten op het gebied van gezondheid en welzijn, en het beheren van onroerend en roerend vermogen.",
"new_text": "Artikel 3. Voorwerp\nDe vennootschap heeft tot voorwerp in Belgi\u00EB en in het buitenland, voor eigen rekening, voor rekening van derden en gezamenlijke rekening met derden.\nDe vennootschap heeft tot voorwerp, zowel in Belgi\u00EB als in het buitenland, voor eigen rekening of voor rekening van derden, of door deelname van dezen:\n- Het oprichten, uitbaten, uitoefenen van bestuursmandaten in en overnemen van",
"change_kind": "amended",
"article_title": "Voorwerp",
"article_number": "3"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "FRANK DESMET",
"org_rep_person_name": null
},
"co_filed_documents": [
"afschrift van de akte",
"geco\u00F6rdineerde tekst van de statuten"
],
"shareholder_rights": null,
"voorwerp_change_summary": "De vennootschap heeft een uitgebreid voorwerp gekregen dat o.a. het oprichten en uitbaten van apotheken en drogisteries, de handel in farmaceutische producten, het uitvoeren van ambachtelijke en industri\u00EBle activiteiten in de farmaceutische sector, de fabricatie van scheikundige en homeopatische producten, en diverse andere diensten op het gebied van gezondheid en welzijn omvat.",
"capital_structure_change": null,
"coordinated_text_lineage": null
}| Legal nameNL | AN VAGENENDE |